Skip to main content
Premium Trial:

Request an Annual Quote

Orion Genomics to Use Genomics Collaborative s Tissue Samples for Cancer Biomarker Discovery

NEW YORK, May 4 (GenomeWeb News) - Genomics Collaborative, a division of SeraCare Life Sciences, said today that it will provide Orion Genomics with annotated clinical tumor tissue specimens for use in Orion's cancer biomarker discovery and validation program.

 

Orion Genomics, a developer of DNA-methylation-based molecular diagnostics, will screen the tissue samples to discover and validate epigenetic biomarkers that are indicative of the presence and stage of disease, Genomics Collaborative said.

 

The deal is the second procurement agreement between the two firms.

 

Additional terms were not disclosed.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.